Related Experiment Video
Updated: Aug 16, 2026

14:47
Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning
Published on: April 21, 2023
Suppression of myoclonus in SCA2 by piracetam
Anna De Rosa1, Pasquale Striano, Fabrizio Barbieri
1Department of Neurological Sciences, Federico II University, Naples, Italy.
Movement Disorders : Official Journal of the Movement Disorder Society
|September 9, 2005
Abstract:
We report on a 30-year-old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations.
